FAF
AGN

Fjarde Ap-fonden’s Allergan plc AGN Stock Holding History

Fjarde Ap-fonden’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-91,308
Closed -$16.2M – 642
2020
Q1 		$16.2M Sell
91,308
-2,100
-2% -$395K 0.26% 80
2019
Q4 		$17.9M Buy
93,408
+200
+0.2% +$36.1K 0.22% 98
2019
Q3 		$15.7M Buy
93,208
+900
+1% +$147K 0.2% 110
2019
Q2 		$15.5M Sell
92,308
-5,600
-6% -$775K 0.2% 113
2019
Q1 		$14.3M Buy
97,908
+16,651
+20% +$2.41M 0.18% 116
2018
Q4 		$10.9M Sell
81,257
-8,400
-9% -$1.38M 0.19% 110
2018
Q3 		$17.1M Sell
89,657
-1,282
-1% -$236K 0.25% 85
2018
Q2 		$15.2M Sell
90,939
-2,996
-3% -$481K 0.23% 93
2018
Q1 		$15.8M Buy
93,935
+99
+0.1% +$16.6K 0.24% 90
2017
Q4 		$15.3M Buy
93,836
+14,187
+18% +$2.55M 0.23% 91
2017
Q3 		$16.3M Buy
79,649
+1,593
+2% +$370K 0.31% 71
2017
Q2 		$19M Buy
78,056
+790
+1% +$186K 0.38% 52
2017
Q1 		$18.5M Sell
77,266
-9,099
-11% -$2.12M 0.44% 41
2016
Q4 		$18.1M Sell
86,365
-7,437
-8% -$1.54M 0.43% 47
2016
Q3 		$21.6M Buy
93,802
+2,623
+3% +$641K 0.47% 42
2016
Q2 		$21.1M Buy
91,179
+1,334
+1% +$308K 0.49% 41
2016
Q1 		$24.1M Buy
89,845
+11,445
+15% +$3.28M 0.56% 40
2015
Q4 		$24.5M Buy
78,400
+526
+0.7% +$157K 0.64% 32
2015
Q3 		$21.2M Sell
77,874
-938
-1% -$288K 0.59% 36
2015
Q2 		$23.9M Sell
78,812
-5,803
-7% -$1.73M 0.58% 36
2015
Q1 		$25.2M Buy
84,615
+21,700
+34% +$6.19M 0.58% 35
2014
Q4 		$16.2M Sell
62,915
-4,205
-6% -$1.05M 0.35% 63
2014
Q3 		$16.2M Buy
67,120
+36,005
+116% +$8.06M 0.35% 62
2014
Q2 		$6.94M Sell
31,115
-7,486
-19% -$1.55M 0.14% 169
2014
Q1 		$7.95M Sell
38,601
-10,060
-21% -$1.99M 0.16% 151
2013
Q4 		$8.18M Buy
48,661
+8,645
+22% +$1.35M 0.17% 135
2013
Q3 		$5.76M Sell
40,016
-1,283
-3% -$171K 0.12% 182
2013
Q2 		$5.21M Buy
+41,299
New +$4.68M 0.11% 211

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Fjarde Ap-fonden's AGN Position: Q2 2020 in Review

Fjarde Ap-fonden sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 91,308 shares — an estimated $16.2M sold.

Fjarde Ap-fonden first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $25.2M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Fjarde Ap-fonden reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Fjarde Ap-fonden sold 91,308 Allergan plc shares in Q2 2020, an estimated $16.2M.
  • Fjarde Ap-fonden first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Fjarde Ap-fonden's Allergan plc position peaked at $25.2M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Fjarde Ap-fonden's 13F filing for Q2 2020, filed 13 Aug 2020.